362 related articles for article (PubMed ID: 24286206)
1. Preparation, characterization and in vitro evaluation of sterically stabilized liposome containing a naphthalenediimide derivative as anticancer agent.
Parise A; Milelli A; Tumiatti V; Minarini A; Neviani P; Zuccari G
Drug Deliv; 2015; 22(5):590-7. PubMed ID: 24286206
[TBL] [Abstract][Full Text] [Related]
2. Sterically stabilized liposomes incorporating the novel anticancer agent phospho-ibuprofen (MDC-917): preparation, characterization, and in vitro/in vivo evaluation.
Mattheolabakis G; Nie T; Constantinides PP; Rigas B
Pharm Res; 2012 Jun; 29(6):1435-43. PubMed ID: 22072052
[TBL] [Abstract][Full Text] [Related]
3. Lyophilization of cholesterol-free PEGylated liposomes and its impact on drug loading by passive equilibration.
Chaudhury A; Das S; Lee RF; Tan KB; Ng WK; Tan RB; Chiu GN
Int J Pharm; 2012 Jul; 430(1-2):167-75. PubMed ID: 22537806
[TBL] [Abstract][Full Text] [Related]
4. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
5. Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma.
Zuccari G; Milelli A; Pastorino F; Loi M; Petretto A; Parise A; Marchetti C; Minarini A; Cilli M; Emionite L; Di Paolo D; Brignole C; Piaggio F; Perri P; Tumiatti V; Pistoia V; Pagnan G; Ponzoni M
J Control Release; 2015 Aug; 211():44-52. PubMed ID: 26031842
[TBL] [Abstract][Full Text] [Related]
6. Formulation kit for liposomal doxorubicin composed of lyophilized liposomes.
Stevens PJ; Lee RJ
Anticancer Res; 2003; 23(1A):439-42. PubMed ID: 12680245
[TBL] [Abstract][Full Text] [Related]
7. PEGylated liposomes of anastrozole for long-term treatment of breast cancer: in vitro and in vivo evaluation.
Shavi GV; Sreenivasa Reddy M; Raghavendra R; Nayak UY; Kumar AR; Deshpande PB; Udupa N; Behl G; Dave V; Kushwaha K
J Liposome Res; 2016; 26(1):28-46. PubMed ID: 25853340
[TBL] [Abstract][Full Text] [Related]
8. The effects of lyophilization on the stability of liposomes containing 5-FU.
Glavas-Dodov M; Fredro-Kumbaradzi E; Goracinova K; Simonoska M; Calis S; Trajkovic-Jolevska S; Hincal AA
Int J Pharm; 2005 Mar; 291(1-2):79-86. PubMed ID: 15707734
[TBL] [Abstract][Full Text] [Related]
9. Vincristine-sulphate-loaded liposome-templated calcium phosphate nanoshell as potential tumor-targeting delivery system.
Thakkar HP; Baser AK; Parmar MP; Patel KH; Ramachandra Murthy R
J Liposome Res; 2012 Jun; 22(2):139-47. PubMed ID: 22149643
[TBL] [Abstract][Full Text] [Related]
10. [Preparation and in vitro and in vivo study of antisense oligodeoxynucleotides-loaded cationic liposomes].
Liu Y; Zhang ZZ; Li K; Mei Q
Yao Xue Xue Bao; 2009 Nov; 44(11):1273-7. PubMed ID: 21355327
[TBL] [Abstract][Full Text] [Related]
11. Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: Effects of cryoprotectants on structure.
Stark B; Pabst G; Prassl R
Eur J Pharm Sci; 2010 Nov; 41(3-4):546-55. PubMed ID: 20800680
[TBL] [Abstract][Full Text] [Related]
12. Sterically stabilized liposomes as a potent carrier for shikonin.
Kontogiannopoulos KN; Tsermentseli SK; Assimopoulou AN; Papageorgiou VP
J Liposome Res; 2014 Sep; 24(3):230-40. PubMed ID: 24597496
[TBL] [Abstract][Full Text] [Related]
13. Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes.
Gabizon AA; Tzemach D; Horowitz AT; Shmeeda H; Yeh J; Zalipsky S
Clin Cancer Res; 2006 Mar; 12(6):1913-20. PubMed ID: 16551877
[TBL] [Abstract][Full Text] [Related]
14. Application of different methods to formulate PEG-liposomes of oxaliplatin: evaluation in vitro and in vivo.
Zalba S; Navarro I; Trocóniz IF; Tros de Ilarduya C; Garrido MJ
Eur J Pharm Biopharm; 2012 Jun; 81(2):273-80. PubMed ID: 22369879
[TBL] [Abstract][Full Text] [Related]
15. Development of a liposomal formulation of the natural flavonoid fisetin.
Mignet N; Seguin J; Ramos Romano M; Brullé L; Touil YS; Scherman D; Bessodes M; Chabot GG
Int J Pharm; 2012 Feb; 423(1):69-76. PubMed ID: 21571054
[TBL] [Abstract][Full Text] [Related]
16. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
Koo OM; Rubinstein I; Onyuksel H
Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
[TBL] [Abstract][Full Text] [Related]
17. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in vivo safety evaluations of antileukemic homoharringtonine-loaded PEGylated liposomes.
Liu D; Xing J; Xiong F; Yang F; Gu N
Drug Dev Ind Pharm; 2017 Apr; 43(4):652-660. PubMed ID: 28005445
[TBL] [Abstract][Full Text] [Related]
19. Polymyxin E sulfate-loaded liposome for intravenous use: preparation, lyophilization, and toxicity assessment in vivo.
Wang D; Kong L; Wang J; He X; Li X; Xiao Y
PDA J Pharm Sci Technol; 2009; 63(2):159-67. PubMed ID: 19634354
[TBL] [Abstract][Full Text] [Related]
20. Effect of sucrose as a lyoprotectant on the integrity of paclitaxel-loaded liposomes during lyophilization.
Kannan V; Balabathula P; Thoma LA; Wood GC
J Liposome Res; 2015; 25(4):270-8. PubMed ID: 25534990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
